$AVDL News Article - Avadel Pharmaceuticals Announces Final FDA Approval of LUMRYZ(TM) (sodium oxybate) for Extended-Release Oral Suspension as the First and Only Once-at-Bedtime Oxybate for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy https://marketwirenews.com/news-releases/avad...61759.html